Table 2. Identification of prognostic factors.
|
|
|
|
Definitive model |
---|---|---|---|---|
Case characteristic | Literaturea | Expert's | Univariate analysis | Multivariate analysis |
Age |
++ |
++ |
++ |
++ |
Lymph node status |
++ |
++ |
− |
− |
Lymfovascular invasion |
+ |
− |
− |
− |
Multifocality |
+ |
++ |
+ |
+ |
Adjuvant chemotherapy |
++ |
+ |
++ |
++ |
Adjuvant radiotherapy |
++ |
++ |
++ |
++ |
Hormonal therapy |
++ |
++ |
++ |
++ |
Invasiveness |
+ |
++ |
− |
− |
Margin status |
++ |
++ |
− |
− |
Gradation |
+ |
+ |
++ |
++ |
Tumour size |
+ |
++ |
++ |
++ |
Ductal/lobular |
+ |
− |
− |
− |
Tumour type | ||||
Luminal A | + | + | + | − |
Luminal B | + | + | − | − |
Triple negative | + | + | + | + |
Her2 positive | + | + | + | − |
++ indicates strong prognostic value; + indicates prognostic value; − indicates no prognostic value.
References are listed in Supplementary Table II.